CT与MRI鉴别自身免疫性胰腺炎与胰腺导管腺癌的Meta分析
该系统综述与Meta分析检索2009至2019年文献,纳入11篇原始研究,比较CT与MRI鉴别自身免疫性胰腺炎(AIP)与胰腺导管腺癌(PDAC)的诊断效能。MRI汇总敏感度84%、特异度97%,CT分别为59%和99%;MRI敏感度显著高于CT(P=0.02),特异度无显著差异(P=0.18)。
要点
- MRI鉴别AIP与PDAC的汇总敏感度84%、特异度97%,CT分别为59%和99%。
- MRI敏感度显著高于CT(84% vs 59%,P=0.02),特异度二者无显著差异(97% vs 99%,P=0.18)。
- 局灶型AIP亚组中,MRI敏感度76% vs CT 50%(P=0.28),特异度97% vs 98%(P=0.07)。
诊断标准与关键数值
- CT鉴别AIP与PDAC的汇总敏感度59%(95%CI 41-75%)、汇总特异度99%(95%CI 88-100%)。
- MRI鉴别AIP与PDAC的汇总敏感度84%(95%CI 68-93%)、汇总特异度97%(95%CI 87-99%)。
- MRI汇总敏感度显著高于CT(84% vs 59%,P=0.02),特异度与CT相似(97% vs 99%,P=0.18)。
- 局灶型AIP亚组中,MRI敏感度76% vs CT 50%(P=0.28),特异度97% vs 98%(P=0.07)。
- 局灶型AIP亚组鉴别局灶型AIP与PDAC的敏感度低于总体分析。
临床应用与阅片要点
- 作者结论认为MRI对评估AIP患者可能临床更有用,尤其用于鉴别AIP与PDAC。
- CT鉴别AIP与PDAC特异度很高(99%)但敏感度欠佳(59%)。
- MRI总体鉴别AIP与PDAC诊断效能良好,汇总敏感度83%、特异度97%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To systematically determine the diagnostic performance of computed tomography (CT) and magnetic resonance imaging (MRI) for differentiating autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC), with a comparison between the two imaging modalities.
METHODS: Literature search was conducted using PubMed and EMBASE databases to identify original articles published between 2009 and 2019 reporting the diagnostic performance of CT and MRI for differentiating AIP from PDAC. The meta-analytic sensitivity and specificity of CT and MRI were calculated, and compared using a bivariate random effects model. Subgroup analysis for differentiating focal AIP from PDAC was performed.
RESULTS: Of the 856 articles screened, 11 eligible articles are remained, i.e., five studies for CT, four for MRI, and two for both. The meta-analytic summary sensitivity and specificity of CT were 59% (95% confidence interval [CI], 41-75%) and 99% (95% CI, 88-100%), respectively, while those of MRI were 84% (95% CI, 68-93%) and 97% (95% CI, 87-99%). MRI had a significantly higher meta-analytic summary sensitivity than CT (84% vs. 59%, p = 0.02) but a similar specificity (97% vs. 99%, p = 0.18). In the subgroup analysis for focal AIP, the sensitivity for distinguishing between focal AIP and PDAC was lower than that for the overall analysis. MRI had a higher sensitivity than CT (76% vs. 50%, p = 0.28) but a similar specificity (97% vs. 98%, p = 0.07).
CONCLUSION: MRI might be clinically more useful to evaluate patients with AIP, particularly for differentiating AIP from PDAC.
KEY POINTS: • MRI had an overall good diagnostic performance to differentiate AIP from PDAC with a meta-analytic summary estimate of 83% for sensitivity and of 97% for specificity. • CT had a very high specificity (99%), but a suboptimal sensitivity (59%) for differentiating AIP from PDAC. • Compared with CT, MRI had a higher sensitivity, but a similar specificity.
引用
- Ha J, Choi SH, Byun JH, et al. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma. Eur Radiol. 2020. PMID: 33146798. doi:10.1007/s00330-020-07416-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。